Ned Pojskic is Green Shield Canada’s Leader for Pharmacy and Health Provider Relations. In this role, he is responsible for setting GSC’s strategic direction with respect to provider and drug benefits management. He takes the lead in managing stakeholder relations with all health care providers, including pharmacy, dental, and paramedical. Pojskic is also responsible for overall drug formulary management, including pricing and policy as well as pharmaceutical industry partnerships.
With an industry background that includes a role as Director of Health Policy for the Ontario Pharmacists Association, Pojskic is a key member of GSC’s Strategic Market Solutions Team. He holds Masters and PhD degrees from the Department of Pharmaceutical Sciences at the University of Toronto and is currently appointed as an adjunct professor within the Leslie Dan Faculty of Pharmacy.
MacKeigan LD, Dolovich L, Petrovic B, MacCallum L, Bojarski EA, Pojskic N. Audit of community pharmacists' prescribing interventions: Quality assessment of a newly reimbursed service. J Am Pharm Assoc (2003). 2018;58(6):622-629.
Marcellus M, Pojskic N. Ontario pharmacists' perceptions of the Pharmaceutical Opinion Program. Can Pharm J (Ott). 2015;148(3):129-133.
Dolovich L, Consiglio G, MacKeigan L, et al. Uptake of the MedsCheck annual medication review service in Ontario community pharmacies between 2007 and 2013 [published correction appears in Can Pharm J (Ott). 2016 Nov;149(6):319]. Can Pharm J (Ott). 2016;149(5):293-302.
Wong L, Burden AM, Liu YY, et al. Initial uptake of the Ontario Pharmacy Smoking Cessation Program: Descriptive analysis over 2 years. Can Pharm J (Ott). 2015;148(1):29-40.
Pojskic N, MacKeigan L, Boon H, Austin Z. Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists. Res Social Adm Pharm. 2014;10(2):341-354.
Pojskic N, Mackeigan L, Boon H, Ellison P, Breslin C. Ontario family physician readiness to collaborate with community pharmacists on drug therapy management. Res Social Adm Pharm. 2011;7(1):39-50.